| ADD | #602-603, 49 Achasan-ro, Seongdong-gu, Seoul, Republic of Korea |
| TEL | 82-2-6259-7371 |
| FAX | 82-2-6259-7370 |
| info@bxplant.co.kr |
About BXPLANT
BXPLANT is a CDRO (Clinical Development and Research Organization) that bridges R&D and clinical development. As a co-development partner, we design integrated strategies encompassing development planning, regulatory affairs, and clinical operations to deliver optimal pathways for drug development.
R&D
CRO
CDRO
Full-Spectrum Development Expertise
Integrated solutions across preclinical strategy, clinical execution, and regulatory affairs—delivering seamless transitions and accelerated timelines from discovery to approval.
Strategic Development Partnership
Beyond conventional CRO services—we integrate development strategy with operational execution, bridging critical gaps from preclinical insight to market realization.
Seamless translation from preclinical to clinical through strategic design and flawless execution. As One Team, we embrace a Sponsor Point of View—delivering adaptive, stage-appropriate solutions with unwavering speed and precision.
Meet Our Leadership: Proven Expertise Driving Your Success
BXPLANT’s leadership team comprises seasoned pharmaceutical and clinical development professionals who have guided countless programs from concept to commercialization. We deliver integrated, sponsor-focused solutions spanning the entire development continuum—identifying promising innovations, architecting strategic development pathways, executing global clinical programs, and facilitating growth capital and partnerships.
Minkeun Jo / Chief Executive Officer
PhD Candidate in Business Administration, Kyung Hee University
Master’s Degree in Pharmacy, Sungkyunkwan University
Master’s Degree in Economics, Korea University
Bachelor’s Program in Law, Chung-Ang University
• Chief Executive Officer, BXPLANT
• Head of Strategic Planning Division, Woojung BIO
• Head of Consumer Healthcare Business Division, Daewoong Pharmaceutical
Heesun Kim PhD, RPh / Chief Executive Officer
PhD in Clinical Research Design, Sungkyunkwan University
Bachelor’s & Master’s Degrees in Pharmacy, Sookmyung Women’s University
• Chief Executive Officer, BXPLANT
Adjunct Professor, Department of Pharmacy, CHA University
• Head of Clinical Development, NextGen Bioscience
• Director of Clinical and Regulatory Affairs, Inventage Lab
• Head of Clinical Development Center, Daewoong Pharmaceutical
Il Hwan Kim DVM, Executive Director
MS & PhD in Veterinary Pathology, Chungnam Nat’l Univ.
- Chief Executive Officer, V1BIO
- AI Drug Discovery / Nonclinical, Daewoong Pharmaceutical
- Pharmacology & Toxicology Team, CJ
- Toxicologic Pathology Team, KRICT TRC
Sung Il Kim, Executive Director
MS in Life Sciences, GIST
- Drug Development Division, ImmunoBiome
- Development Strategy, Y-Biologics
- Drug Development Division, TSD Life Science
- Clinical Development Team, LG Life Sciences
Su Young Lee BN, Director
BN, Dongguk Univ. College of Medicine
- Clinical Development Team, Jeil Pharmaceutical
- Clinical Development Center, Daewoong Pharmaceutical
- Clinical Team, Sewon Cellontech
Ji Young You, Director
MBA in Strategy/Management, Yonsei Univ.
MS in Biological Sciences, Seoul Nat’l Univ.
- Clinical Development Strategy, NA Vaccine Inst.
- Clinical Development Strategy, CKD
- Clinical Science, HANDOK
- MW Team, DreamCIS
Jung Hyun Yoo RPh, Executive Director
BSc in Medicinal Chemistry, Sookmyung Women’s Univ.
- Clinical Team, Daewoong Pharmaceutical
- Panolos Bioscience
- BNP Lab
Eun Hye Kim, Director
MS in Statistics, Dongguk Univ.
- Medical Device Dept., Synex
- Clinical Statistics Team, Synex
- DM·STAT, Hanmi Pharmaceutical
- DM·STAT, CKD
Yu Kyong Kim PhD, Team Lead
PhD in Biomedical Sciences, Seoul Nat’l Univ.
BSc in Biomedical Science, Univ. of Sheffield, UK
- Clinical / RA·QA Team, GoBioLab
- Clinical Strategy Planning, BASGEN Bio
- Clinical Team, Daewoong Pharmaceutical
- Research Prof., Clinical Pharmacology and Therapeutics, CBNUH
Jeong Ah Yoon, Team Lead
MS in Biotechnology, Konkuk Univ.
- Clinical Development Team, Progen Pharmaceuticals
- Product Strategy RA, CGBio
- Global BD, Daewoong Pharmaceutical
- Licensing & Registration Team, Overseas Certification Management Center
Donghwee Kim, Team Lead
- Clinical Team, Boryung Pharmaceutical
- Clinical Team, Medytox
Soo Hee Bae, Team Lead
MS in Medical Statistics, Yonsei Univ.
- DM·STAT, Medytox
- DM·STAT, CKD
Seulki Kim, Team Lead
MS in Nursing, Korea Univ.
- Clinical Strategy Office, Boryung Pharmaceutical
- Clinical Center, Addpharma
- Medical Affairs Division, Green Cross
Haesung Jung, Team Lead
BSc in Computer Engineering, HUFS
- Clinical Statistics Team, MBIO
- Clinical Statistics Team, PPC Korea
- DM, BioInfra
Hong Chul Yoon PhD, Advisor / Professor
PhD in Biomedical Science & Medicinal Chemistry, Yonsei Univ.
- Inst. of Convergence Technology, Yonsei Univ.
- Advisor, S2C Bio
- Executive Director, Yunovia
- Central Research Inst., IL-DONG Pharm.
- Postdoc, Calibr (CA, USA)
Jung Jin Lee PhD, Advisor
PhD in Microbiology (Immunology), Seoul Nat’l Univ.
- Chief Executive Officer, CKD Bio
- R&D Division, Binex
- Bio Research Inst., Daewoong Pharm.
- Vaccine Business Division, LG Life Sciences
Hyun Joo Kim, Advisor
MS in Chemistry, Pusan Nat’l Univ.
- IP & R&D Planning, AptaBio
- R&D Planning, Daewoong Pharm.
- R&D Strategy Team, Daewoong Pharm.
- Central Research Inst., JW Pharm.
Won No Yoon, Partner
MS in Pharmaceutical Sciences, Sungkyunkwan Univ.
- Central Research Inst., Onyu Pharm.
- New Drug Research Lab., Ahn-Gook Pharm.
- New Drug Research Lab., SK Chemicals
